Chart looks good and valuation is low but sold half into recent...

Chart looks good and valuation is low but sold half into recent strength as I’m expecting a CR this week or next. Most of the buy volume has been from canaccord and we know cash balances are low per the last 4C. Canaccord are their broker and raises start again from this week - brokers often buy pre raise to get the price to an acceptable level for the client - after the standard discount of course.

Even with low capex of $15m for Paulsens plus working capital we’re still looking at up to a $20m raise (potentially of course) which is more than half the market cap.

I am keeping the other half as LEL and Peru options are just too compelling. Let’s see how this plays out...